SAB Biotherapeutics, Inc. (SABS)

SAB Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	9.17	56.57	15.05	33.21	12.61	6.35
Cash & Short-Term Investments	30.4	56.57	15.05	33.21	12.61	6.35
Cash Growth	1153.39%	275.93%	-54.69%	163.33%	98.71%	-
Receivables	0.1	-	5.56	8.01	20.57	2.82
Prepaid Expenses	2.04	2.34	1.49	2.64	1.28	0.12
Restricted Cash	-	-	-	6.34	-	-
Total Current Assets	32.54	58.91	22.1	50.19	34.46	9.29
Property, Plant & Equipment	20.75	24.68	28.34	30.95	22.08	8.71
Other Long-Term Assets	0.25	0.35	0.47	-	-	-
Total Assets	53.8	83.94	50.9	81.14	56.54	18
Accounts Payable	1.3	0.95	3.68	4.46	7.38	2.17
Accrued Expenses	6.88	6.69	9.83	11.91	1.28	0.5
Short-Term Debt	-	-	-	-	-	1.36
Current Portion of Long-Term Debt	-	1.05	0.77	1.8	0.54	0.03
Current Portion of Leases	0.52	0.8	0.62	1.3	1.12	0.55
Current Unearned Revenue	0.11	1.32	-	0.1	0.1	-
Other Current Liabilities	-	-	0.09	6.89	0.64	-
Total Current Liabilities	8.82	10.81	14.99	26.46	11.06	4.62
Long-Term Debt	-	-	0.54	-	0.17	0.05
Long-Term Leases	4	4.05	3.99	5.42	6.3	5.64
Other Long-Term Liabilities	4.08	11.77	0.32	10.72	-	-
Total Liabilities	16.89	26.64	19.85	42.59	17.53	10.31
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	155.14	152.86	84.45	67.67	50.99	29.79
Retained Earnings	-112.77	-90.06	-47.87	-29.13	-11.98	-32.1
Treasury Stock	-5.52	-5.52	-5.52	-	-	-
Comprehensive Income & Other	0.05	0.03	-	-	-	-
Total Common Equity	36.9	57.3	31.06	38.55	39.01	-2.31
Shareholders' Equity	36.9	57.3	31.06	38.55	39.01	7.69
Total Liabilities & Equity	53.8	83.94	50.9	81.14	56.54	18
Total Debt	4.52	5.91	5.93	8.52	8.13	7.64
Net Cash (Debt)	25.88	50.66	9.12	24.69	4.48	-1.29
Net Cash Growth	-	455.59%	-63.07%	450.61%	-	-
Net Cash Per Share	3.00	9.17	2.09	9.03	1.66	-0.37
Filing Date Shares Outstanding	9.23	9.23	5.04	4.3	3.52	3.52
Total Common Shares Outstanding	9.23	9.23	5.04	4.35	3.52	3.52
Working Capital	23.72	48.09	7.1	23.74	23.39	4.67
Book Value Per Share	4.00	6.21	6.16	8.86	11.08	-0.66
Tangible Book Value	36.9	57.3	31.06	38.55	39.01	-2.31
Tangible Book Value Per Share	4.00	6.21	6.16	8.86	11.08	-0.66
Machinery	14.48	11.99	11.57	8.87	6.33	2.31
Construction In Progress	0.02	-	0.31	4.61	6.73	0.08
Leasehold Improvements	15.42	9.3	9.3	5.7	0.19	0.03

Source: S&P Capital IQ. Standard template. Financial Sources.